Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

[Safety and efficacy of FOLFOX and FOLFIRI in elderly patients with colorectal cancer].

Mishima H, Ikenaga M, Yasui M.

Nihon Rinsho. 2011 Apr;69 Suppl 3:554-8. Japanese. No abstract available.

PMID:
22214022
[PubMed - indexed for MEDLINE]
2.

Impact of neoadjuvant chemotherapy with FOLFOX/FOLFIRI on disease-free and overall survival of patients with colorectal metastases.

Boostrom SY, Nagorney DM, Donohue JH, Harmsen S, Thomsen K, Que F, Kendrick M, Reid-Lombardo KM.

J Gastrointest Surg. 2009 Nov;13(11):2003-9; discussion 2009-10. doi: 10.1007/s11605-009-1007-3. Epub 2009 Sep 16.

PMID:
19760306
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies.

Ohtani H, Arimoto Y, Nishio K, Kanamiya Y, Oba H, Adachi K, Shintani M, Nakamura R, Yui S.

Gan To Kagaku Ryoho. 2008 Oct;35(10):1769-74.

PMID:
18931586
[PubMed - indexed for MEDLINE]
4.

Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.

Liang XB, Hou SH, Li YP, Wang LC, Zhang X, Yang J.

Chin Med J (Engl). 2010 Nov;123(22):3314-8.

PMID:
21163137
[PubMed - indexed for MEDLINE]
Free Article
5.

Chemotherapy of metastatic colorectal cancer.

[No authors listed]

Prescrire Int. 2010 Oct;19(109):219-24. Review.

PMID:
21180382
[PubMed - indexed for MEDLINE]
6.

Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study).

Hebbar M, Tournigand C, Lledo G, Mabro M, André T, Louvet C, Aparicio T, Flesch M, Varette C, de Gramont A; Oncology Multidisciplinary Research Group (GERCOR).

Cancer Invest. 2006 Mar;24(2):154-9.

PMID:
16537184
[PubMed - indexed for MEDLINE]
7.

[Results of neo-adjuvant chemotherapy by FOLFOX and FOLFIRI for colorectal liver metastasis].

Amano R, Yamada N, Noda E, Kubo N, Tanaka H, Muguruma K, Inoue T, Yashiro M, Maeda K, Onoda N, Sawada T, Nakata B, Ohira M, Ishikawa T, Hirakawa K.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2003-5. Japanese.

PMID:
20037305
[PubMed - indexed for MEDLINE]
8.

A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.

Tumeh JW, Shenoy PJ, Moore SG, Kauh J, Flowers C.

Am J Clin Oncol. 2009 Feb;32(1):49-55. doi: 10.1097/COC.0b013e31817c6a4d.

PMID:
19194125
[PubMed - indexed for MEDLINE]
9.

[A review of FOLFOXIRI chemotherapy for the 1st line treatment of metastatic colorectal cancer].

Kawakami H, Satoh T, Nakagawa K.

Nihon Rinsho. 2011 Apr;69 Suppl 3:439-45. Review. Japanese. No abstract available.

PMID:
22214001
[PubMed - indexed for MEDLINE]
10.

Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG).

Vamvakas L, Athanasiadis A, Karampeazis A, Kakolyris S, Polyzos A, Kouroussis Ch, Ziras N, Kalbakis K, Georgoulias V, Souglakos J.

Crit Rev Oncol Hematol. 2010 Oct;76(1):61-70. doi: 10.1016/j.critrevonc.2009.08.003. Epub 2009 Sep 3.

PMID:
19729318
[PubMed - indexed for MEDLINE]
11.

[Development of taste disorders following FOLFOX-FOLFIRI therapy and its effects on the QOL of patients with colorectal cancer].

Takimoto N, Sugawara S, Iida A, Sakakibara T, Mori K, Sugiura M, Yamamura K, Adachi M.

Gan To Kagaku Ryoho. 2009 Mar;36(3):431-5. Japanese.

PMID:
19295267
[PubMed - indexed for MEDLINE]
12.

Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin.

Bao HY, Fang WJ, Zhang XC, Shi GM, Huang S, Yu LF, Chen J, Mou HB, Deng J, Shen P, Xu N.

Cancer Chemother Pharmacol. 2011 Jan;67(1):147-52. doi: 10.1007/s00280-010-1301-5. Epub 2010 Mar 11.

PMID:
20221830
[PubMed - indexed for MEDLINE]
13.

Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.

[No authors listed]

Prescrire Int. 2005 Dec;14(80):230-3.

PMID:
16400749
[PubMed - indexed for MEDLINE]
14.

[Reflexion on a good strategy of use of oxaliplatine with 5-fluorouracil and its derivatives in patients with advanced colorectal cancer].

Tournigand C, de Gramont A.

Bull Cancer. 2006 Feb 1;93 Suppl 1:S11-5. French.

PMID:
16483941
[PubMed - indexed for MEDLINE]
15.

A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma.

Catania C, Pelosi G, Fazio N, Biffi R, Spitaleri G, Noberasco C, Zampino MG, Maggioni A, Trifirò G, Toffalorio F, Vigna PD, De Braud F, De Pas T.

Acta Oncol. 2010;49(1):120-1. doi: 10.3109/02841860903081913. No abstract available.

PMID:
20100147
[PubMed - indexed for MEDLINE]
16.

Clinical and economic evaluation of first-line therapy with FOLFIRI or modified FOLFOX6 for metastatic colorectal cancer.

Ajima H, Ogata H, Fujita K, Miwa K, Sunakawa Y, Mizuno K, Ishida H, Yamashita K, Nakayama H, Kawara K, Takahashi H, Sasaki Y.

Jpn J Clin Oncol. 2010 Jul;40(7):634-8. doi: 10.1093/jjco/hyq029.

PMID:
20587616
[PubMed - indexed for MEDLINE]
Free Article
17.

Combination chemotherapy and colorectal cancer.

Sumpter K, Cunningham D.

Semin Oncol. 2000 Oct;27(5 Suppl 10):105-11. Review. No abstract available.

PMID:
11049041
[PubMed - indexed for MEDLINE]
18.

Second-line therapy in colorectal cancer.

Berlin J.

Oncology (Williston Park). 2000 Dec;14(12 Suppl 11):21-6. Review.

PMID:
11204658
[PubMed - indexed for MEDLINE]
19.

Second line therapies move to the forefront in colorectal cancer.

Miller M.

J Natl Cancer Inst. 1999 Jun 16;91(12):998-1000. No abstract available.

PMID:
10379961
[PubMed - indexed for MEDLINE]
Free Article
20.

Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

Folprecht G, Köhne CH, Lutz MP.

Cancer Treat Res. 2007;134:425-40. Review. No abstract available.

PMID:
17633071
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk